Cold Plasma Market to Witness Remarkable CAGR of 16.3% by 2028, Driven by Increasing Demand for Sustainable Solutions

The "Cold Plasma Market" is expected to be worth US$ 1.40 Billion by the end of 2018 and, while growing at a CAGR of 16.3% from 2018 to 2026, is anticipated to reach US$ 51.31 Billion by that year.

Click Here to Get Free Sample Copy of this Report https://www.persistencemarketresearch.com/samples/17053

Cold plasma, also known as non-thermal plasma, is a type of plasma that operates at or near room temperature. It is created by applying a high voltage electrical discharge to a gas or liquid, which generates a plasma field that contains various reactive species, such as ions, electrons, and free radicals.

The cold plasma technology is used in various applications, including surface treatment, sterilization, wound healing, and cancer treatment. The market for cold plasma is growing due to the increasing demand for eco-friendly and sustainable solutions in various industries, such as healthcare, food, and electronics.

Browse Full Report@ https://www.persistencemarketresearch.com/market-research/cold-plasma-market.asp

Competitive Landscape:
The global cold plasma market is highly competitive, with the presence of several major players. Some of the key players in the market include Linde AG, Nordson Corporation, ADTEC Plasma Technology Co., Ltd., Plasmatreat GmbH, Bovie Medical Corporation, Neoplas Tools GmbH, Europlasma NV, Tantec A/S, Henniker Plasma, Vetaphone A/S. These players are focusing on product innovation, mergers and acquisitions, and partnerships to gain a competitive edge in the market.

Market Drivers and Restraints:
The increasing use of cold plasma in the medical industry for the treatment of chronic wounds, cancer, and other diseases is expected to drive the growth of the market. The growing demand for eco-friendly and sustainable packaging solutions, where cold plasma is used for surface treatment, is also driving the market. The growing awareness regarding the benefits of cold plasma technology and the increasing investments in research and development activities are expected to boost the market growth.

However, the high cost of cold plasma equipment and the lack of awareness regarding the benefits of cold plasma technology in developing countries are expected to hinder the growth of the market to some extent.

Buy this Premium Research Report https://www.persistencemarketresearch.com/checkout/17053

Market Segmentation:
Based on the application, the market can be segmented into surface treatment, wound healing, sterilization, cancer treatment, and others. The surface treatment segment is expected to dominate the market due to the growing demand for eco-friendly and sustainable solutions in the food and electronics industries.

Based on the regime, the market can be segmented into atmospheric pressure plasma and low-pressure plasma. Atmospheric pressure plasma is the most widely used regime due to its ability to operate at room temperature and pressure, making it suitable for a wide range of applications.

Based on the end-user, the market can be segmented into healthcare, food and agriculture, electronics and semiconductors, textiles, and others. The healthcare segment is expected to dominate the market due to the growing demand for advanced wound care solutions and the use of cold plasma in cancer treatment.

Customize this Report As per Your Requirement Click Here https://www.persistencemarketresearch.com/request-customization/17053

Regional Analysis:
North America and Europe are expected to dominate the market, owing to the presence of major players and the increasing use of cold plasma technology in the medical industry. Asia Pacific is expected to grow at the highest CAGR during the forecast period, owing to the increasing investments in research and development activities and the growing demand for eco-friendly and sustainable packaging solutions in the region.

Recent Developments
• In January 2022, SteriPlas, a medical technology company, announced the successful completion of a clinical study that demonstrated the efficacy of cold plasma technology in treating chronic wounds. The study showed a significant reduction in wound size and healing time in patients treated with SteriPlas' cold plasma technology.
• In November 2021, a team of researchers from the University of California, Berkeley developed a new method for producing cold plasma that is more efficient and cost-effective than existing methods. The new method uses a low-power laser to generate plasma, which could potentially make cold plasma technology more accessible to a wider range of industries.
• In September 2021, Coldplasmatech, a German manufacturer of cold plasma systems, announced the launch of a new product line of air purifiers that use cold plasma technology to neutralize viruses and bacteria in the air. The company aims to help schools, offices, and other public spaces reduce the risk of infection and create a safer environment.

Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:
The Chemicals and Materials division of Persistence Market Research offers distinct and pin-point analysis about chemicals and materials industry. Chemical coverage extends from commodity, bulk, specialty and petrochemicals to advanced materials, composites and nanotechnology in particular with special emphasis on 'green alternatives', recycling and renewable technology developments, supply-demand-trade assessment. Our research studies are widely referred by chemical manufacturers, research institutions, channel partners and government bodies for developing - 'The Way Forward'.

This release was published on openPR.